Benjamin F. Edwards & Company’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
$32K Sell
391
-3
-0.8% -$246 ﹤0.01% 1435
2024
Q1
$35K Sell
394
-39
-9% -$3.46K ﹤0.01% 1395
2023
Q4
$42K Buy
433
+249
+135% +$24.2K ﹤0.01% 1293
2023
Q3
$16K Sell
184
-44
-19% -$3.83K ﹤0.01% 1292
2023
Q2
$20K Hold
228
﹤0.01% 1275
2023
Q1
$22K Sell
228
-18
-7% -$1.74K ﹤0.01% 1251
2022
Q4
$25K Buy
246
+43
+21% +$4.37K ﹤0.01% 1230
2022
Q3
$17K Sell
203
-1,026
-83% -$85.9K ﹤0.01% 1292
2022
Q2
$102K Sell
1,229
-1,526
-55% -$127K ﹤0.01% 850
2022
Q1
$212K Sell
2,755
-758
-22% -$58.3K 0.01% 671
2021
Q4
$310K Buy
3,513
+286
+9% +$25.2K 0.01% 571
2021
Q3
$249K Sell
3,227
-680
-17% -$52.5K 0.01% 603
2021
Q2
$326K Sell
3,907
-168
-4% -$14K 0.02% 529
2021
Q1
$308K Buy
4,075
+1,012
+33% +$76.5K 0.02% 570
2020
Q4
$269K Buy
3,063
+1,542
+101% +$135K 0.02% 560
2020
Q3
$116K Buy
1,521
+314
+26% +$23.9K 0.01% 708
2020
Q2
$149K Buy
1,207
+1,188
+6,253% +$147K 0.01% 638
2020
Q1
$2K Hold
19
﹤0.01% 1578
2019
Q4
$2K Sell
19
-920
-98% -$96.8K ﹤0.01% 1756
2019
Q3
$63K Buy
939
+893
+1,941% +$59.9K ﹤0.01% 857
2019
Q2
$4K Buy
46
+19
+70% +$1.65K ﹤0.01% 1660
2019
Q1
$2K Hold
27
﹤0.01% 1600
2018
Q4
$2K Hold
27
﹤0.01% 1578
2018
Q3
$3K Hold
27
﹤0.01% 1460
2018
Q2
$3K Hold
27
﹤0.01% 1460
2018
Q1
$2K Hold
27
﹤0.01% 1502
2017
Q4
$2K Sell
27
-15
-36% -$1.11K ﹤0.01% 1441
2017
Q3
$4K Hold
42
﹤0.01% 1307
2017
Q2
$4K Buy
+42
New +$4K ﹤0.01% 1249